Novamind to Introduce Novel Psychedelic Treatment Protocol in Online Workshop
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Phase 1b/2a Trial With a Proprietary Long-Acting GLP-1 Agonist in Short Bowel Syndrome Top-Line Data Expected in Q4 Continued Enrollment...
Eye tracking system developers are pushing for strategic partnerships with software businesses for easier integration of new technologies in offerings...
JACKSON CENTER, PA / ACCESSWIRE / November 9, 2020 / Halberd Corp. (OTC PINK:HALB) reported the filing of a Covid-19...
Expert oncologists will work with Epsilogen to guide the clinical program for its lead candidate, MOv18 IgE LONDON, UK /...
Continued progress on oncology and COVID-19 vaccine programs Over $117 million of cash and short-term investments DURHAM, NC / ACCESSWIRE...
National In-Home Blood Sample Collection Through ExamOne® and Metro Health Staffing, LLC FT MEYERS, FL / ACCESSWIRE / November 9,...
Planet 13 generated $7.6 million in revenue in October at gross margins above 50% LAS VEGAS, NV / ACCESSWIRE /...
· PDC-1421, the active ingredient of ABV-1505, is being expanded into adult ADHD trials following encouraging Phase II trial results in...
ST. LOUIS, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the...
FREDERICK, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ) is a global company specializing in...
Jushi Europe begins development of best-in-class, sustainable greenhouse cultivation facility BOCA RATON, Fla., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Jushi...
SRF388 inhibits hepatocellular carcinoma tumor growth as a single agent in a preclinical model SRF114 induces destruction of tumor Tregs...
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced...
CMP-001 in combination with pembrolizumab continues to demonstrate durable responses in anti-PD-1 refractory melanoma in ongoing trial Encouraging new data on...
Results demonstrated that ADAIR had slower absorption and lower early exposure, and was less desirable to recreational drug abusers on...
MONTREAL, Nov. 09, 2020 (GLOBE NEWSWIRE) -- ATW Tech Inc. (the "Company" or "ATW Tech") (TSX-V: ATW) is pleased to...
IND filing today for STI-2020 (COVI-AMG™) for the treatment of COVID-19 in patients with mild symptoms and a separate safety...
Revenue remained strong in Q3 Castellum, Inc. (OTC: ONOV) announces filing its third quarter (Q3) operating results. Revenue for Q3...
KANSAS CITY, Mo., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Today, Cerner Corporation (NASDAQ: CERN), a global health care technology company,...